Stable schizophrenia patients switched to paliperidone palmitate 3-monthly formulation in real life: functioning and resource use

被引：1
|
作者：
Garcia-Portilla, P. [1 ]
Llorca, P. M. [2 ]
Maina, G. [3 ]
Bozikas, V. P. [4 ]
Devrimci-Ozguven, H. [5 ]
Kim, S. W. [6 ]
Bergmans, P. [7 ]
Usankova, I. [8 ]
Cherubin, P. [9 ]
Pungor, K. [10 ]
机构：
[1] Univ Oviedo, Cibersam, Oviedo, Spain
[2] CHR Univ Clermont Ferrand, Pole Psychiat, Clermont Ferrand, France
[3] Univ Torino, SCDU Psichiat, AOU San Luigi Gonzaga, Turin, Italy
[4] Aristotle Univ Thessaloniki, Dept Psychiat, Sch Med, Thessaloniki, Greece
[5] Ankara Univ, Sch Med, Dept Psychiat, Ankara, Turkey
[6] Chonnam Natl Univ, Med Sch, Gwangju, South Korea
[7] Janssen Cilag Biostat & Programming, Biostat & Programming, Breda, Netherlands
[8] Johnson & Johnson, Med Affairs Org, Moscow, Russia
[9] Janssen Cilag, EMEA Med Affairs, Issy Les Moulineaux, France
[10] Janssen Cilag, EMEA Med Affairs, Dusseldorf, Germany
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
REMISSION;
D O I：
10.1016/j.euroneuro.2018.11.383
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.272
引用
收藏
页码：S238 / S239
页数：2
相关论文
共 50 条
  • [21] Paliperidone palmitate 3-monthly formulation in schizophrenia - baseline interim analysis of a naturalistic, 52-week, prospective study
    Hargarter, L.
    Bergmans, P.
    Usankova, I.
    Cherubin, P.
    EUROPEAN PSYCHIATRY, 2018, 48 : S107 - S108
  • [22] Determinants of Caregiver Burden in Family Carers of Asian Patients with Schizophrenia treated with Paliperidone Palmitate 3-monthly injectable
    Gopal, Srihari
    Xu Haiyan
    Savitz, Adam
    Nuamah, Isaac
    Woodruff, Kimberly
    Mathews, Maju
    Lu Yu
    Zhuo Jianmin
    Feng Yu
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 234 - 235
  • [23] Effects of Long-acting Injectable 3-Monthly Paliperidone Palmitate on the Clinical and Social Performance of Patients with Schizophrenia
    Oh, Jihoon
    Oh, Jihye
    Kim, Dong Wook
    Youn, HyunChul
    Kim, Sae-Hoon
    Kim, Soo In
    Chung, In Won
    Wang, Kuan Shu
    Kim, Minah
    Paik, Jong -Woo
    Koh, Min Jung
    Lee, Yoosun
    Choi, Seok Young
    Kim, Jung-Jin
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2023, 21 (01) : 126 - 134
  • [24] Symptomatic Remission and Functional Recovery after Paliperidone Palmitate 3-monthly or 1-monthly treatment in Asian Patients with Exacerbated Schizophrenia
    Savitz, Adam
    Xu, Haiyan
    Gopal, Srihari
    Nuamah, Isaac
    Hough, David
    Mathews, Maju
    Feng, Yu
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 242 - 243
  • [25] Paliperidone palmitate intramuscular 6-monthly formulation in schizophrenia: a profile of its use
    Blair, Hannah A.
    DRUGS & THERAPY PERSPECTIVES, 2022, 38 (08) : 335 - 342
  • [26] Paliperidone palmitate intramuscular 6-monthly formulation in schizophrenia: a profile of its use
    Hannah A. Blair
    Drugs & Therapy Perspectives, 2022, 38 : 335 - 342
  • [27] Paliperidone Palmitate 3-Monthly Versus 1-Monthly Injectable in Patients With Schizophrenia With or Without Prior Exposure to Oral Risperidone or Paliperidone: A Post Hoc, Subgroup Analysis
    Maju Mathews
    Huiling Pei
    Adam Savitz
    Isaac Nuamah
    David Hough
    Larry Alphs
    Srihari Gopal
    Clinical Drug Investigation, 2018, 38 : 695 - 702
  • [28] New Zealand community mental healthcare provider experience in schizophrenia management with 3-monthly paliperidone palmitate
    Cassidy, Cathal
    Miles, Wayne
    AUSTRALASIAN PSYCHIATRY, 2021, 29 (03) : 299 - 304
  • [29] Paliperidone Palmitate 3-Monthly Versus 1-Monthly Injectable in Patients With Schizophrenia With or Without Prior Exposure to Oral Risperidone or Paliperidone: A Post Hoc, Subgroup Analysis
    Mathews, Maju
    Pei, Huiling
    Savitz, Adam
    Nuamah, Isaac
    Hough, David
    Alphs, Larry
    Gopal, Srihari
    CLINICAL DRUG INVESTIGATION, 2018, 38 (08) : 695 - 702
  • [30] Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia : A Critical Appraisal
    Garcia-Carmona, Juan Antonio
    Pappa, Sofia
    DRUG HEALTHCARE AND PATIENT SAFETY, 2023, 15 : 113 - 123
12345